Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at MSK, has been awarded the Pasteur-Weizmann/Servier International Prize. Dr. Sadelain was chosen in recognition of his pivotal research demonstrating the therapeutic potential of engineered T cells. Dr. Sadelain will accept the 2018 Pasteur-Weizmann Prize at a ceremony held at the French Academy of Sciences in Paris, France on Tuesday, October 16, 2018.
“I am honored to receive this award and I look forward to expanding my research on T cell engineering and the clinical development of chimeric antigen receptors (CAR) therapy,” Dr. Sadelain says.
The Pasteur-Weizmann/Servier International Prize was established in 2003 by three scientific research centers: L’Institut Servier, the Institut Pasteur, and the Weizmann Institute of Sciences. Given every three years, the award is conferred upon a biomedical researcher and his or her team for a major contribution leading to therapeutic application. This year’s prize focused on the field of immuno-regulation and cancer. Awardees receive up to 250,000 euros to support their work.